Concerns on ranibizumab and zoledronic acid safety for experimentally treating women with endometriosis. - Barra F; Ferro Desideri L; Gustavino C; Ferrero S; Traverso CE; Nicolò M (Archives of gynecology and obstetrics, 2022)